Lupin eyes 3-fold hike in revenues

Drug major Lupin is eyeing a nearly three-fold increase in its revenues at $5 billion by 2018 as it looks to grow its business organically and by acquiring companies and brands.

“My vision for Lupin, from Rs 5,000 to $5 billion in 50 years, is but the beginning for bigger more pertinent goal, a happier tomorrow,” Lupin Ltd Founder Chairman Desh Bandhu Gupta said in the company’s Annual Report (2012-13). For 2012-13 fiscal, the company’s net sales grew by 35.9 per cent to Rs 9,461.6 crore ($1.74 billion).

“All our businesses continue to unlock value on a sustained basis with robust performance being delivered by US and Europe, India, Japan and South Africa,” Lupin Ltd Managing Director Kamal K Sharma said.

Comments (+)